Nirmala Bhoo Pathy, Professor at the University of Malaya and Adjunct Professor at Kasturba Medical College, Manipal, shared a post on LinkedIn:
“A retrospective review in JCO Oncology Practice analyzed the cost impact of second opinions in oncology.
Findings? Subspecialist second opinions in oncology most often resulted in a de-escalation of care intensity.
Meaning? Safer, less aggressive treatment (like avoiding major surgery or shifting drug regimens) while aiming for the same outcomes. The fiscal outcome? Lower overall spending, with an average savings of $15,015 across the patient cohort.
We need more of this sort of research!”
Title: What Is the Cost Impact of Second Opinions in Oncology? A Retrospective Review
Authors: Benjamin R. Roman, Allison Lipitz-Snyderman, Susan Chimonas, Brendan Raftery, Cole Manship, Arushi Mahajan, Leonard Saltz, Aaron Mitchell, David Miller, Smita Sihag, Daniel Gomez, Bobby Daly, Lauren Klein Levine
Read the Full Article.
More posts featuring Nirmala Bhoo Pathy.